What’s the current state of allergy care in the US? (Triple Aim approach) episode artwork

EPISODE · Aug 26, 2024 · 26 MIN

What’s the current state of allergy care in the US? (Triple Aim approach)

from ImmunoCAST · host Thermo Fisher Scientific

Using the Triple Aim framework to dissect the current status of allergy care in America, this episode delves into the per capita cost, population health, and patient experience of care, emphasizing the importance of accurate diagnosis and appropriate referrals. Tune in for insights on improving healthcare efficiency, reducing costs, and enhancing patient outcomes. Don't miss this informative episode designed to help clinicians better serve their patients. Episode resources and references available at https://www.thermofisher.com/phadia/us/en/resources/immunocast/s2e5.html?cid=0ct_3pc_05032024_9SGOV4

Episode metadata supplied by the publisher feed · Published Aug 26, 2024

Embed this episode

Ready to play

What’s the current state of allergy care in the US? (Triple Aim approach)

0:00 26:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ImmunoCAST?

This episode is 26 minutes long.

When was this ImmunoCAST episode published?

This episode was published on August 26, 2024.

Can I download this ImmunoCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!